Abstract

Abstract Summary

Epidemiology studies including case-control, cohort, time trend, and case studies focused on the impact of radiofrequency radiation (RFR) from mobile and wireless devices are summarized. These follow the International Agency for Research on Cancer (IARC) 2011's classification of RFR as a potential carcinogen.

Key Findings

• Glioma Association: The presence of glioma linked to RFR in multiple studies within Sweden, France, and beyond.
• Growing Trends: An increasing trend in glioma incidents has been noticed in the UK and other locations.
• Non-Malignant Risks: Links to acoustic neuroma and meningioma were observed alongside increased brain cancer potentials.
• Strength of Evidence: Recent animal studies combined with epidemiology reinforce that RFR could be reclassified as Group 1 (carcinogenic to humans).

Conclusions and Recommendations

The accumulated data from epidemiological studies along with animal research supports upgrading RFR to a Group 1 carcinogen. The studies suggest further investigation into other potential tumor types and emphasize the importance of epidemiological research to back policy changes and exposure prevention.